On September 6th, 2019, Louis Vermeulen gave his inaugural lecture to officially accept his position as newly appointed professor of Molecular Oncology.
The newest publication of the Vermeulen lab is featured on the cover of Nature Protocols. The paper details methodology for clonal tracing in established colon cancer tissue using marker-independent fluorescent labelling.
See: https://www.nature.com/nprot/volumes/14/issues/9 for more details.
In the recent funding round, KWF granted two projects from the Vermeulen Lab.
Daniel Miedema was awarded a Young Investigator Grant for his project on tumor growth in colorectal cancer.
Nicolas Leveille, together with Louis Vermeulen and Cornelis Murre (UCSD) received a grant for the project “Wnt-regulated long noncoding RNAs as Achilles’ heel of colorectal cancers”
With an amazing combined time of 05:31:56, The LEXOR team Vermeulen 1 won the Cruyff Legacy 14 K Run!
You can see the official results of our team here.
A new paper about the spatiotemporal regulation of clonogenicity in colorectal cancer xenografts has been published in PNAS. Check it out here.
After being nominated by their AG&M PI’s and selected by members of the AG&M research board, five contestants (Arwen Gao, Lowiek Hubers, Sophie Lodestijn, Sofia El Manouni El Hassani (for Daan Berkhout) and Ivo Hansen) pitched their first authorship publication from 2018 during the AG&M symposium: Complex Genetics of Metabolic Disease. The audience voted for the best pitch. Sophie Lodestijn and Arwen Gao had exactly the same amount of votes and have been awarded the 2018 AG&M best publication prize.
See the Louis Vermeulen Oncode page here.
Louis Vermeulen received the proof-of-concept grant from the European Research Council. The project aims at development of a nanobody targeting Osteopontin to inhibit the development of colorectal cancer.
Louis Vermeulen is featured in the Stem Cell Podcast, Ep. 126: “Cancer Environment”.